0001415889-21-005036.txt : 20211102
0001415889-21-005036.hdr.sgml : 20211102
20211101210202
ACCESSION NUMBER: 0001415889-21-005036
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211101
FILED AS OF DATE: 20211101
DATE AS OF CHANGE: 20211101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chapman Steven Leonard
CENTRAL INDEX KEY: 0001711968
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 211368962
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD, SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
4
1
form4-11012021_061153.xml
X0306
4
2021-11-01
0001604821
Natera, Inc.
NTRA
0001711968
Chapman Steven Leonard
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
AUSTIN
TX
78753
true
true
false
false
CEO AND PRESIDENT
Common Stock
2021-11-01
4
S
0
80
113.0050
D
37023
D
Common Stock
2021-11-01
4
S
0
420
114.9138
D
36603
D
Common Stock
2021-11-01
4
S
0
1017
116.1035
D
35586
D
Common Stock
2021-11-01
4
M
0
3052
9.29
A
38638
D
Common Stock
2021-11-01
4
M
0
2084
20.27
A
40721
D
Common Stock
2021-11-01
4
S
0
200
113.01
D
40521
D
Common Stock
2021-11-01
4
S
0
1106
114.7320
D
39415
D
Common Stock
2021-11-01
4
S
0
3389
115.9887
D
36026
D
Common Stock
2021-11-01
4
S
0
440
116.4970
D
35586
D
Stock Option (right to buy)
9.29
2021-11-01
4
M
0
3052
0
D
2028-03-08
Common Stock
3052
15263
D
Stock Option (right to buy)
20.27
2021-11-01
4
M
0
2083
0
D
2029-04-11
Common Stock
2083
35417
D
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2021,
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.00 to $113.01 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.56 to $115.46 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.60 to $116.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021, as amended on May 14, 2021.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.44 to $115.20 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.45 to $116.44 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.46 to $116.5950 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
/s/ Tami Chen, Attorney-in-Fact
2021-11-01